Northrop Grumman Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Benzinga Earnings
07/21

Northrop Grumman Corporation (NYSE:NOC) will release its second quarter earnings report before the opening bell on Tuesday, July 21.

Analysts expect the Falls Church, Virginia-based company to report quarterly earnings of $6.82 per share, down from $8.15 per share in the year-ago period. The consensus estimate for Northrop Grumman’s quarterly revenue is $10.8 billion. It reported $10.35 billion last year, according to Benzinga Pro.

On April 21, Northrop Grumman posted upbeat first-quarter earnings.

Shares of Northrop Grumman gained 0.5% to close at $523.96 on Monday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let’s have a look at how Benzinga’s most-accurate analysts have rated the company in the recent period.

  • Goldman Sachs analyst Noah Poponak maintained a Neutral rating and cut the price target from $603 to $533 on July 14, 2026. This analyst has an accuracy rate of 65%.
  • TD Cowen analyst Gautam Khanna maintained a Hold rating and lowered the price target from $680 to $580 on July 13, 2026. This analyst has an accuracy rate of 74%.
  • Citigroup analyst John Godyn maintained a Buy rating and cut the price target from $628 to $587 on July 1, 2026. This analyst has an accuracy rate of 52%.
  • Jefferies analyst Sheila Kahyaoglu maintained a Hold rating and cut the price target from $620 to $580 on June 26, 2026. This analyst has an accuracy rate of 73%.
  • UBS analyst Gavin Parsons maintained a Buy rating and slashed the price target from $806 to $745 on April 23, 2026. This analyst has an accuracy rate of 66%

Considering buying NOC stock? Here’s what analysts think:

Photo via Shutterstock

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10